Abstract:Introduction: Abnormal iron metabolism has received increasing attention in the development of liver injury. Recent findings have shown that iron metabolism may be associated with elevated alanine aminotransferase (ALT), and the aim of this study was to investigate the relationship between iron metabolism-related indicators and elevated ALT.Methods: Based on the data of Chinese adults aged 18 years and older in the China Health and Nutrition Survey (CHNS), we analyzed the correlations between glucose, lipid, and iron metabolism-related indicators and elevated ALT, and explored iron metabolism-related indicators affecting ALT levels using binary logistic regression models.Results: Serum ferritin levels and transferrin levels were positively correlated with elevated ALT. The OR of elevated ALT in the highest serum ferritin level group was 7.34 (95% CI: 4.66-11.54, P<0.001) compared to the lowest serum ferritin level group. The OR for elevated ALT in the highest transferrin group was 3.65 (95% CI: 2.34-5.68, P < 0.001) compared to the lowest transferrin group. In addition, hypoplasticemia was significantly associated with an increased risk of elevated ALT (OR=3.98, 95%IC: 2.16-7.34, P<0.001). These relationships persisted after adjustment for covariates.Conclusion: High ferritin and transferrin levels and hypoplasticemia are associated with elevated ALT. Unexplained elevation of ALT may suggest the development of metabolic-associated fatty liver disease (MAFLD), so this study provides clues to investigate the role of iron metabolism in the pathogenesis of MAFLD.Funding Information: The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.Declaration of Interests: The authors declare that the research was conducted in the absence of any financial relationships that could be construed as a potential conflict of interest.Ethics Approval Statement: Data of this study was from the China Health and Nutrition Survey (CHNS). CHNS was approved by the Institutional Review Committees of the University of North Carolina at Chapel Hill and the National Institute of Nutrition and Food Safety, Chinese Center for Disease Control and Prevention. This research uses data from China Health and Nutrition Survey (CHNS). We thank the National Institute for Nutrition and Health, China Center for Disease Control and Prevention, Carolina Population Center (P2C HD050924, T32 HD007168), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the NIH Fogarty International Center (D43 TW009077, D43 TW007709) for financial support for the CHNS data collection and analysis files from 1989 to 2015 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009, Chinese National Human Genome Center at Shanghai since 2009, and Beijing Municipal Center for Disease Prevention and Control since 2011.

Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China

Relationship Between Alanine Aminotransferase Levels and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

Associations of Cumulative Exposure to Metal Mixtures with Metabolic Dysfunction-Associated Fatty Liver Disease in a Chinese Aged Population

Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease

Alanine Aminotransferase Is Associated With An Adverse Nocturnal Blood Glucose Profile In Individuals With Normal Glucose Regulation

Association Between Serum Uric Acid Levels and Long-Term Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease: a Nationwide Cohort Study

Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study.

Lower Alanine Aminotransferase Levels Are Associated with Increased All-Cause and Cardiovascular Mortality in Nonalcoholic Fatty Liver Patients.

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

Associations Between Abnormal Iron Metabolism and Elevated Alanine Aminotransferase in Adults

Association between alanine aminotransferase to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: a retrospective cohort study in lean Chinese individuals

Associations of Acrylamide with Non-Alcoholic Fatty Liver Disease in American Adults: a Nationwide Cross-Sectional Study

Compare the Prevalence of Metabolic Abnormalities in the Patients with Fatty Liver or Elevated Alanine Aminiotransferase

Association of Serum Alanine Aminotransferase with Metabolic Syndrome in Middle-Aged and Elderly Chinese

Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling

Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States

Altitude and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in China: A Population-Based Study

Association of low alanine aminotransferase with loss of independence or death: A 5-year population-based cohort study

High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study

Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China

Changes in alanine aminotransferase and body composition and metabolic factors among individuals receiving medical health checkups